Assessment of kidney transplant suitability for patients with prior cancers: is it time for a rethink?

Wai H. Lim, Eric Au, Anoushka Krishnan, Germaine Wong

Research output: Contribution to journalReview article

Abstract

Kidney transplant recipients have up to a 100-fold greater risk of incident cancer compared with the age/sex-matched general population, attributed largely to chronic immunosuppression. In patients with a prior history of treated cancers, the type, stage and the potential for cancer recurrence post-transplant of prior cancers are important factors when determining transplant suitability. Consequently, one of the predicaments facing transplant clinicians is to determine whether patients with prior cancers are eligible for transplantation, balancing between the accelerated risk of death on dialysis, the projected survival benefit and quality of life gains with transplantation, and the premature mortality associated with the potential risk of cancer recurrence post-transplant. The guidelines informing transplant eligibility or screening and preventive strategies against cancer recurrence for patients with prior cancers are inconsistent, underpinned by uncertain evidence on the estimates of the incidence of cancer recurrence and the lack of stage-specific outcomes data, particularly among those with multiple myeloma or immune-driven malignancies such as melanomas. With the advent of newer anti-cancer treatment options, it is unclear whether the current guidelines for those with prior cancers remain appropriate. This review will summarize the uncertainties of evidence informing the current recommendations regarding transplant eligibility of patients with prior cancers.

Original languageEnglish
JournalTransplant International
DOIs
Publication statusE-pub ahead of print - 6 Aug 2019

Fingerprint

Transplants
Kidney
Neoplasms
Recurrence
Transplantation
Guidelines
Premature Mortality
Multiple Myeloma
Immunosuppression
Uncertainty
Dialysis
Melanoma
Quality of Life
Survival
Incidence
Population

Cite this

@article{83693c6242d644dea18e713bc61e4db8,
title = "Assessment of kidney transplant suitability for patients with prior cancers: is it time for a rethink?",
abstract = "Kidney transplant recipients have up to a 100-fold greater risk of incident cancer compared with the age/sex-matched general population, attributed largely to chronic immunosuppression. In patients with a prior history of treated cancers, the type, stage and the potential for cancer recurrence post-transplant of prior cancers are important factors when determining transplant suitability. Consequently, one of the predicaments facing transplant clinicians is to determine whether patients with prior cancers are eligible for transplantation, balancing between the accelerated risk of death on dialysis, the projected survival benefit and quality of life gains with transplantation, and the premature mortality associated with the potential risk of cancer recurrence post-transplant. The guidelines informing transplant eligibility or screening and preventive strategies against cancer recurrence for patients with prior cancers are inconsistent, underpinned by uncertain evidence on the estimates of the incidence of cancer recurrence and the lack of stage-specific outcomes data, particularly among those with multiple myeloma or immune-driven malignancies such as melanomas. With the advent of newer anti-cancer treatment options, it is unclear whether the current guidelines for those with prior cancers remain appropriate. This review will summarize the uncertainties of evidence informing the current recommendations regarding transplant eligibility of patients with prior cancers.",
keywords = "kidney transplant, melanoma, myeloma, Prior cancers, transplant suitability",
author = "Lim, {Wai H.} and Eric Au and Anoushka Krishnan and Germaine Wong",
year = "2019",
month = "8",
day = "6",
doi = "10.1111/tri.13486",
language = "English",
journal = "Transplant International",
issn = "0934-0874",
publisher = "John Wiley & Sons",

}

Assessment of kidney transplant suitability for patients with prior cancers : is it time for a rethink? / Lim, Wai H.; Au, Eric; Krishnan, Anoushka; Wong, Germaine.

In: Transplant International, 06.08.2019.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Assessment of kidney transplant suitability for patients with prior cancers

T2 - is it time for a rethink?

AU - Lim, Wai H.

AU - Au, Eric

AU - Krishnan, Anoushka

AU - Wong, Germaine

PY - 2019/8/6

Y1 - 2019/8/6

N2 - Kidney transplant recipients have up to a 100-fold greater risk of incident cancer compared with the age/sex-matched general population, attributed largely to chronic immunosuppression. In patients with a prior history of treated cancers, the type, stage and the potential for cancer recurrence post-transplant of prior cancers are important factors when determining transplant suitability. Consequently, one of the predicaments facing transplant clinicians is to determine whether patients with prior cancers are eligible for transplantation, balancing between the accelerated risk of death on dialysis, the projected survival benefit and quality of life gains with transplantation, and the premature mortality associated with the potential risk of cancer recurrence post-transplant. The guidelines informing transplant eligibility or screening and preventive strategies against cancer recurrence for patients with prior cancers are inconsistent, underpinned by uncertain evidence on the estimates of the incidence of cancer recurrence and the lack of stage-specific outcomes data, particularly among those with multiple myeloma or immune-driven malignancies such as melanomas. With the advent of newer anti-cancer treatment options, it is unclear whether the current guidelines for those with prior cancers remain appropriate. This review will summarize the uncertainties of evidence informing the current recommendations regarding transplant eligibility of patients with prior cancers.

AB - Kidney transplant recipients have up to a 100-fold greater risk of incident cancer compared with the age/sex-matched general population, attributed largely to chronic immunosuppression. In patients with a prior history of treated cancers, the type, stage and the potential for cancer recurrence post-transplant of prior cancers are important factors when determining transplant suitability. Consequently, one of the predicaments facing transplant clinicians is to determine whether patients with prior cancers are eligible for transplantation, balancing between the accelerated risk of death on dialysis, the projected survival benefit and quality of life gains with transplantation, and the premature mortality associated with the potential risk of cancer recurrence post-transplant. The guidelines informing transplant eligibility or screening and preventive strategies against cancer recurrence for patients with prior cancers are inconsistent, underpinned by uncertain evidence on the estimates of the incidence of cancer recurrence and the lack of stage-specific outcomes data, particularly among those with multiple myeloma or immune-driven malignancies such as melanomas. With the advent of newer anti-cancer treatment options, it is unclear whether the current guidelines for those with prior cancers remain appropriate. This review will summarize the uncertainties of evidence informing the current recommendations regarding transplant eligibility of patients with prior cancers.

KW - kidney transplant

KW - melanoma

KW - myeloma

KW - Prior cancers

KW - transplant suitability

UR - http://www.scopus.com/inward/record.url?scp=85071318066&partnerID=8YFLogxK

U2 - 10.1111/tri.13486

DO - 10.1111/tri.13486

M3 - Review article

JO - Transplant International

JF - Transplant International

SN - 0934-0874

ER -